Search Results 91-100 of 16066 for pharmacogenetics
The center has established service lines in cancer, rare and undiagnosed diseases, pharmacogenomics, and predictive genomics and is integrating these services ...
Corifact™ or Tretten® is a man-made protein produced to replicate the naturally occurring factor XIII in the body. It is used to stop bleeding by helping the ...
The Center for Individualized Medicine aligns its programs across four pillars: Functional Omics, Digital Omics, Population Omics and Rare Disease Omics.
The department performs more than 20 million laboratory tests annually in support of the Mayo Clinic practice and more than 4,000 Mayo Clinic Laboratories ...
... pharmacogenetic studies in clinical protocols to include development and validation of assays for genetic variants of proteins associated with drug response.
In one study, she investigates a series of biomarkers related to the initial treatment for patients with estrogen receptor-positive, or ER+, breast cancer with ...
The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy. Genes. 2023; doi:10.3390/genes14051095. Henssler J, et al ...
The Mayo Clinic Center for Individualized Medicine's Bioinformatics Program processes, analyzes and interprets raw genomic sequencing data.
About this study. Tapestry is a Mayo Clinic research study, which includes receiving genetic sequencing data from Helix, up to the full whole exome dataset.
Pharmacogenetic testing (such as cytochrome P450 2D6 and 2C19, serotonin transporter gene); Transcranial magnetic stimulation; Psychotherapy techniques (such ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.